EP Patent

EP0334083A1 — Ifosfamid-Mesna-Lyophilisat und Verfahren zu dessen Herstellung

Assigned to Asta Medica GmbH · Expires 1989-09-27 · 37y expired

What this patent protects

Ifosfamid-Mesna-Lyophilisat, bestehend im wesentlichen aus Ifosfamid, 0,1 - 1,0 Gewichtsteilen Mesna und 0,1 bis 17 Gewichtsteilen Hexit.

USPTO Abstract

Ifosfamid-Mesna-Lyophilisat, bestehend im wesentlichen aus Ifosfamid, 0,1 - 1,0 Gewichtsteilen Mesna und 0,1 bis 17 Gewichtsteilen Hexit.

Drugs covered by this patent

bendamustine-hydrochloride (BENDAMUSTINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP0334083A1
Jurisdiction: EP
Classification: —
Expires: 1989-09-27
Drug substance claim: No
Drug product claim: No
Assignee: Asta Medica GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.